Latest KFF Health News Content

Latest KFF Health News Stories

Financial Crunch Of Pandemic Hits Health Care Workers

Morning Briefing

The financial toll is forcing some to delay retirement, Modern Healthcare reports. Other news on medical workers covers doctors’ battle against COVID misinformation, discrimination claims and opioid-related charges.

Azar Lays Out New Vaccine Timetable

Morning Briefing

According to the HHS secretary, the most vulnerable Americans could receive the vaccine by the end of this year. Seniors, health care workers and first responders could get it by the end of January. Everyone else could receive it “by the end of March to early April.” Azar’s timetable differs from the one laid out earlier this month by the CDC and NIH. Meanwhile, Politico reports that Azar could oust FDA chief Stephen Hahn over vaccine disputes.

What Does ‘Close Contact’ Mean? CDC Redefines COVID Exposure Time To Qualify

Morning Briefing

The CDC previously defined the time and distance during which COVID-19 could be transmitted as 15 continuous minutes within six feet of an infectious person. Now they say that time window could be cumulative over a 24-hour period.

Online Child Abuse, Exploitation Has Spiked During Pandemic, Officials Say

Morning Briefing

In other news related to children’s health: A New Orleans archbishop has asked all diocesan priests on his list of religious men credibly accused of molesting children to leave the Catholic clergy entirely; and youth advocates in Texas say the state is not doing enough to protect detainees in juvenile prisons from physical and sexual abuse.

‘Distressing’ Third COVID Surge Leaves Hospitals, States Scrambling

Morning Briefing

At least 75 percent of the U.S. is experiencing a spike in new COVID-19 infections, the CDC warns. Things are particularly worrisome in the Midwest. And the worst could still be yet to come, as the winter holidays could increase transmissions.

Californians Asked to Pony Up for Stem Cell Research — Again

KFF Health News Original

More than a decade of research tied to California’s stem cell agency hasn’t yielded many cures or much revenue. But backers of a ballot initiative that asks voters for billions more in funding say the work is vital for patients and the scientific community.